# Efficacy of Sildenafil in Preterm Preeclampsia

> **NCT02782559** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **The University of Texas Health Science Center, Houston**

## Conditions studied

- Preterm Preeclampsia

## Interventions

- **DRUG:** Sildenafil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02782559
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-07
- **Primary completion:** 2017-07
- **Final completion:** 2017-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** difficulties acquiring the drug and funding for the drug
- **Last updated:** 2018-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02782559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02782559, "Efficacy of Sildenafil in Preterm Preeclampsia". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT02782559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*